English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models Journal article
Ye-Piao Yan, Jia-Yue Chen, Jia-Hong Lu. Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(23), 15238.
Authors:  Ye-Piao Yan;  Jia-Yue Chen;  Jia-Hong Lu
Favorite | TC[WOS]:12 TC[Scopus]:13  IF:4.9/5.6 | Submit date：2023/01/30
Huperzine a  Alzheimer’s Disease  Animal Studies  Preclinical Studies  Meta-analysis  Systematic Review  
Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future Conference paper
Khan, Harron, Jawad, Mohammad, Kamal, Mohammad Amjad, Baldi, Alessandra, Xiao, Jianbo, Nabavi, Seyed Mohammad, Daglia, Maria. Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future[C], THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND:PERGAMON-ELSEVIER SCIENCE LTD, 2018, 355-367.
Authors:  Khan, Harron;  Jawad, Mohammad;  Kamal, Mohammad Amjad;  Baldi, Alessandra;  Xiao, Jianbo; et al.
Favorite | TC[WOS]:67 TC[Scopus]:77 | Submit date：2018/10/30
Antiplatelet  Preclinical Studies  Structure-activity Relationship (Sar) Studies  Pharmacokinetic Parameters  Safety Profile  
Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future Journal article
Khan H., Jawad M., Kamal M.A., Baldi A., Xiao J., Nabavi S.M., Daglia M.. Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future[J]. Food and Chemical Toxicology, 2018, 119, 355-367.
Authors:  Khan H.;  Jawad M.;  Kamal M.A.;  Baldi A.;  Xiao J.; et al.
Favorite | TC[WOS]:67 TC[Scopus]:77 | Submit date：2019/01/15
Antiplatelet  Pharmacokinetic Parameters  Preclinical Studies  Safety Profile  Structure-activity Relationship (Sar) Studies